Extensive Serum Biomarker Analysis in Patients with Nasopharyngeal Carcinoma.

Daoyuan Gong,Ziping Li,Rui Ding,Min Cheng,Huakun Huang,Aiping Liu,Mei Kang,Haijian He,Ying Xu,Jing Shao,Yong Wang,Chaohui Duan

DOI: https://doi.org/10.1016/j.cyto.2018.04.031

IF: 3.926

2019-01-01

Cytokine

Abstract:Nasopharyngeal carcinoma (NPC) is a fast-growing cancer characterized by high occurrences of nodal and distant metastases and poor prognosis. It is therefore important to identify new serum biomarkers for the early diagnosis and prognostic prediction of this disease. The present study identifies biomarkers in NPC patient serum using a solid-phase antibody array detecting the expression profiles of 174 cytokines in a single experiment. ELISA was performed to validate the array results. The levels of TIMP-2, SELL, CCL24, MMP-1, MMP-3, IGF-I and IL-8 were significantly higher in serum from NPC patients, while the levels of MSP-alpha and HCC-4 were lower. Furthermore, the validation results were identical to those obtained from the antibody array. These results indicate that these cytokines might serve as novel biomarkers for the diagnosis and prognostic prediction of NPC.